{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:38:56Z","timestamp":1791589136447,"version":"4.3.4"},"reference-count":162,"publisher":"BMFH Press","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.12938\/bmfh.2025-042","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T22:08:42Z","timestamp":1760652522000},"page":"85-99","source":"Crossref","is-referenced-by-count":1,"title":["Gut microbiota: a potential therapeutic target for hyperuricemia and gout"],"prefix":"10.12938","volume":"45","author":[{"given":"Jiahui","family":"TANG","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Center for Diabetes and              Metabolism Research, West China Hospital of Sichuan University, No. 37 GuoXue Lane,              Chengdu 610041, China"},{"name":"Center for Diabetes and Metabolism Research, West China Hospital of Sichuan              University, No. 37 GuoXue Lane, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxi","family":"LIU","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Center for Diabetes and              Metabolism Research, West China Hospital of Sichuan University, No. 37 GuoXue Lane,              Chengdu 610041, China"},{"name":"Center for Diabetes and Metabolism Research, West China Hospital of Sichuan              University, No. 37 GuoXue Lane, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianwei","family":"WU","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Center for Diabetes and              Metabolism Research, West China Hospital of Sichuan University, No. 37 GuoXue Lane,              Chengdu 610041, China"},{"name":"Center for Diabetes and Metabolism Research, West China Hospital of Sichuan              University, No. 37 GuoXue Lane, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"LU","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout,              The Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao, Shandong              266003, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"ZHANG","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Center for Diabetes and              Metabolism Research, West China Hospital of Sichuan University, No. 37 GuoXue Lane,              Chengdu 610041, China"},{"name":"Center for Diabetes and Metabolism Research, West China Hospital of Sichuan              University, No. 37 GuoXue Lane, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanwei","family":"TONG","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Center for Diabetes and              Metabolism Research, West China Hospital of Sichuan University, No. 37 GuoXue Lane,              Chengdu 610041, China"},{"name":"Center for Diabetes and Metabolism Research, West China Hospital of Sichuan              University, No. 37 GuoXue Lane, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingguo","family":"L\u00dc","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Center for Diabetes and              Metabolism Research, West China Hospital of Sichuan University, No. 37 GuoXue Lane,              Chengdu 610041, China"},{"name":"Center for Diabetes and Metabolism Research, West China Hospital of Sichuan              University, No. 37 GuoXue Lane, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5076","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bardin              T, Richette              P. 2017.            Impact of comorbidities on gout and hyperuricaemia: an update on            prevalence and treatment options. BMC Med 15: 123.","DOI":"10.1186\/s12916-017-0890-9"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. He              Q, Mok              TN, Sin              TH, Yin              J, Li              S, Yin              Y, Ming              WK, Feng              B. 2023.            Global, regional, and national prevalence of gout from 1990 to 2019:            age-period-cohort analysis with future burden prediction. JMIR            Public Health Surveill 9: e45943.","DOI":"10.2196\/45943"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Almeida              A, Mitchell              AL, Boland              M, Forster              SC, Gloor              GB, Tarkowska              A, Lawley              TD, Finn              RD. 2019.            A new genomic blueprint of the human gut microbiota.            Nature 568: 499\u2013504.","DOI":"10.1038\/s41586-019-0965-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hill              C, Guarner              F, Reid              G, Gibson              GR,                Merenstein              DJ, Pot              B, Morelli              L, Canani              RB, Flint              HJ, Salminen              S, et            al. 2014. Expert consensus document.            The International Scientific Association for Probiotics and Prebiotics consensus            statement on the scope and appropriate use of the term probiotic.            Nat Rev Gastroenterol Hepatol 11:            506\u2013514.","DOI":"10.1038\/nrgastro.2014.66"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tang              C, Li              L, Jin              X, Wang              J, Zou              D, Hou              Y, Yu              X, Wang              Z, Jiang              H. 2024.            Investigating the impact of gut microbiota on gout through mendelian            randomization. Orthop Res Rev 16:            125\u2013136.","DOI":"10.2147\/ORR.S454211"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Liu              Y, Jarman              JB, Low              YS, Augustijn              HE, Huang              S, Chen              H, DeFeo              ME, Sekiba              K, Hou              BH, Meng              X, et            al. 2023. A widely distributed gene            cluster compensates for uricase loss in hominids.          Cell 186: 3400\u20133413.e20.","DOI":"10.1016\/j.cell.2023.06.010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fan              S, Huang              Y, Lu              G, Sun              N, Wang              R, Lu              C, Ding              L, Han              J, Zhou              J, Li              Y, et            al. 2022. Novel anti-hyperuricemic            hexapeptides derived from <i>Apostichopus japonicus<\/i> hydrolysate and their            modulation effects on the gut microbiota and host microRNA profile.            Food Funct 13:          3865\u20133878.","DOI":"10.1039\/D1FO03981D"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tong              S, Zhang              P, Cheng              Q, Chen              M, Chen              X, Wang              Z, Lu              X, Wu              H. 2022.            The role of gut microbiota in gout: is gut microbiota a potential target            for gout treatment. Front Cell Infect Microbiol 12: 1051682.","DOI":"10.3389\/fcimb.2022.1051682"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wang              J, Chen              Y, Zhong              H, Chen              F, Regenstein              J, Hu              X, Cai              L, Feng              F. 2022.            The gut microbiota as a target to control hyperuricemia pathogenesis:            potential mechanisms and therapeutic strategies. Crit Rev Food            Sci Nutr 62: 3979\u20133989.","DOI":"10.1080\/10408398.2021.1874287"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yamada              N, Iwamoto              C, Kano              H, Yamaoka              N, Fukuuchi              T, Kaneko              K, Asami              Y. 2016.            Evaluation of purine utilization by <i>Lactobacillus              gasseri<\/i> strains with potential to decrease the absorption of food-derived            purines in the human intestine. Nucleosides Nucleotides Nucleic            Acids 35: 670\u2013676.","DOI":"10.1080\/15257770.2015.1125000"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kasahara              K, Kerby              RL, Zhang              Q, Pradhan              M, Mehrabian              M, Lusis              AJ, Bergstr\u00f6m              G, B\u00e4ckhed              F, Rey              FE. 2023.            Gut bacterial metabolism contributes to host global purine            homeostasis. Cell Host Microbe 31:          1038\u20131053.e10.","DOI":"10.1016\/j.chom.2023.05.011"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Li              M, Yang              D, Mei              L, Yuan              L, Xie              A, Yuan              J. 2014.            Screening and characterization of purine nucleoside degrading lactic acid            bacteria isolated from Chinese sauerkraut and evaluation of the serum uric acid lowering            effect in hyperuricemic rats. PLoS One 9: e105577.","DOI":"10.1371\/journal.pone.0105577"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Xu              YX, Liu              LD, Zhu              JY, Zhu              SS, Ye              BQ, Yang              JL, Huang              JY, Huang              ZH, You              Y, Li              WK, et            al. 2024. Alistipes            indistinctus-derived hippuric acid promotes intestinal urate excretion to alleviate            hyperuricemia. Cell Host Microbe 32:            366\u2013381.e9.","DOI":"10.1016\/j.chom.2024.02.001"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Song              S, Lou              Y, Mao              Y, Wen              X, Fan              M, He              Z, Shen              Y, Wen              C, Shao              T. 2022.            Alteration of gut microbiome and correlated amino acid metabolism            contribute to hyperuricemia and Th17-driven inflammation in <i>Uox<\/i>-KO            mice. Front Immunol 13:            804306.","DOI":"10.3389\/fimmu.2022.804306"},{"key":"15","unstructured":"15. Wang              L, Fang              ZR, Shen              YT, Liu              YB, Liu              LL. 2017.            Effects of <i>Clostridium butyricum <\/i>on serum uric acid and            inflammatory mediators in rats with hyperuricemia. Nan Fang Yi            Ke Da Xue Xue Bao 37:            678\u2013682 (in Chinese)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Shaaban              MI,                Abdelmegeed              E, Ali              YM. 2015.            Cloning, expression, and purification of recombinant uricase enzyme from            pseudomonas aeruginosa Ps43 using <i>Escherichia coli<\/i>.            J Microbiol Biotechnol 25:            887\u2013892.","DOI":"10.4014\/jmb.1410.10041"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Yin              H, Liu              N, Chen              J. 2022.            The role of the intestine in the development of            hyperuricemia. Front Immunol 13:            845684.","DOI":"10.3389\/fimmu.2022.845684"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Martinon              F. 2010.            Signaling by ROS drives inflammasome activation.            Eur J Immunol 40:            616\u2013619.","DOI":"10.1002\/eji.200940168"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Cri\u015fan              TO, Cleophas              MCP,                Novakovic              B, Erler              K, van de                Veerdonk              FL,                Stunnenberg              HG, Netea              MG, Dinarello              CA, Joosten              LAB. 2017.            Uric acid priming in human monocytes is driven by the AKT-PRAS40            autophagy pathway. Proc Natl Acad Sci USA 114: 5485\u20135490.","DOI":"10.1073\/pnas.1620910114"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Liu              W, Peng              J, Wu              Y, Ye              Z, Zong              Z, Wu              R, Li              H. 2023.            Immune and inflammatory mechanisms and therapeutic targets of gout: an            update. Int Immunopharmacol 121:            110466.","DOI":"10.1016\/j.intimp.2023.110466"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. McLoughlin              RF, Berthon              BS, Jensen              ME, Baines              KJ, Wood              LG. 2017.            Short-chain fatty acids, prebiotics, synbiotics, and systemic            inflammation: a systematic review and meta-analysis. Am J Clin            Nutr 106: 930\u2013945.","DOI":"10.3945\/ajcn.117.156265"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Koh              A, De Vadder              F,                Kovatcheva-Datchary              P, B\u00e4ckhed              F. 2016.            From dietary fiber to host physiology: short-chain fatty acids as key            bacterial metabolites. Cell 165:            1332\u20131345.","DOI":"10.1016\/j.cell.2016.05.041"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sun              M, Wu              W, Liu              Z, Cong              Y. 2017.            Microbiota metabolite short chain fatty acids, GPCR, and inflammatory            bowel diseases. J Gastroenterol 52:            1\u20138.","DOI":"10.1007\/s00535-016-1242-9"},{"key":"24","unstructured":"24. Liu              Z, Sun              M. 2018.            Microbiota, intestinal mucosal immunity and inflammatory bowel            diseases. Chinese J Digestion 38:          758\u2013761 (in Chinese)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Lin              MY, de Zoete              MR, van                Putten              JPM, Strijbis              K. 2015.            Redirection of epithelial immune responses by short-chain fatty acids            through inhibition of histone deacetylases. Front            Immunol 6: 554.","DOI":"10.3389\/fimmu.2015.00554"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Zhao              Y, Chen              F, Wu              W, Sun              M, Bilotta              AJ, Yao              S, Xiao              Y, Huang              X,                Eaves-Pyles              TD, Golovko              G, et            al. 2018. GPR43 mediates microbiota            metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial            cells via activation of mTOR and STAT3. Mucosal            Immunol 11: 752\u2013762.","DOI":"10.1038\/mi.2017.118"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Gurav              A,                Sivaprakasam              S, Bhutia              YD, Boettger              T, Singh              N, Ganapathy              V. 2015.            Slc5a8, a Na+-coupled high-affinity transporter for short-chain fatty            acids, is a conditional tumour suppressor in colon that protects against colitis and            colon cancer under low-fibre dietary conditions. Biochem            J 469: 267\u2013278.","DOI":"10.1042\/BJ20150242"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Haghikia              A, J\u00f6rg              S, Duscha              A, Berg              J, Manzel              A, Waschbisch              A, Hammer              A, Lee              DH, May              C, Wilck              N, et            al. 2015. Dietary fatty acids directly            impact central nervous system autoimmunity via the small intestine.            Immunity 43: 817\u2013829.","DOI":"10.1016\/j.immuni.2015.09.007"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Park              J, Kim              M, Kang              SG, Jannasch              AH, Cooper              B, Patterson              J, Kim              CH. 2015.            Short-chain fatty acids induce both effector and regulatory T cells by            suppression of histone deacetylases and regulation of the mTOR-S6K            pathway. Mucosal Immunol 8:            80\u201393.","DOI":"10.1038\/mi.2014.44"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Sanchez              HN, Moroney              JB, Gan              H, Shen              T, Im              JL, Li              T, Taylor              JR, Zan              H, Casali              P. 2020.            B cell-intrinsic epigenetic modulation of antibody responses by dietary            fiber-derived short-chain fatty acids. Nat            Commun 11: 60.","DOI":"10.1038\/s41467-019-13603-6"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Yao              Y, Cai              X, Zheng              Y, Zhang              M, Fei              W, Sun              D, Zhao              M, Ye              Y, Zheng              C. 2022.            Short-chain fatty acids regulate B cells differentiation via the FFA2            receptor to alleviate rheumatoid arthritis. Br J            Pharmacol 179: 4315\u20134329.","DOI":"10.1111\/bph.15852"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Da\u00efen              CI, Tan              J, Audo              R, Mielle              J, Quek              LE, Krycer              JR, Angelatos              A, Duraes              M, Pinget              G, Ni              D, et            al. 2021. Gut-derived acetate promotes            B10 cells with antiinflammatory effects. JCI            Insight 6: e144156.","DOI":"10.1172\/jci.insight.144156"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wu              W, Sun              M, Chen              F, Cao              AT, Liu              H, Zhao              Y, Huang              X, Xiao              Y, Yao              S, Zhao              Q, et            al. 2017. Microbiota metabolite            short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is            mediated by GPR43. Mucosal Immunol 10:            946\u2013956.","DOI":"10.1038\/mi.2016.114"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Roberfroid              M, Gibson              GR, Hoyles              L, McCartney              AL, Rastall              R, Rowland              I, Wolvers              D, Watzl              B, Szajewska              H, Stahl              B, et            al. 2010. Prebiotic effects: metabolic            and health benefits. Br J Nutr 104 Suppl 2: S1\u2013S63.","DOI":"10.1017\/S0007114510003363"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Nemati              M, Ebrahimi              B,                Montazeri-Najafabady              N. 2024.            Probiotics ameliorate endocrine disorders via modulating inflammatory            pathways: a systematic review. Genes Nutr 19: 7.","DOI":"10.1186\/s12263-024-00743-8"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Choi              C, Jeong              YL, Park              KM, Kim              M, Kim              S, Jo              H, Lee              S, Kim              H, Choi              G, Choi              YH, et            al. 2024. TM4SF19-mediated control of            lysosomal activity in macrophages contributes to obesity-induced inflammation and            metabolic dysfunction. Nat Commun 15:            2779.","DOI":"10.1038\/s41467-024-47108-8"},{"key":"37","unstructured":"37. Liu              Y, Li              M, Duan              L, Yuan              J. 2023.            Dysbiosis of gut microbiota in hyperuricemia: research            progress. Zhongguo Weishengtaixue Zazhi 35: 229\u2013233 (in          Chinese)."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Yang              X, Liu              D, Zhao              X, Han              Y, Zhang              X, Zhou              Q, Lv              Q. 2024.            Hyperuricemia drives intestinal barrier dysfunction by regulating gut            microbiota. Heliyon 10:            e36024.","DOI":"10.1016\/j.heliyon.2024.e36024"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Guo              Y, Li              H, Liu              Z, Li              C, Chen              Y, Jiang              C, Yu              Y, Tian              Z. 2019.            Impaired intestinal barrier function in a mouse model of            hyperuricemia. Mol Med Rep 20:            3292\u20133300.","DOI":"10.3892\/mmr.2019.10586"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Lv              Q, Xu              D, Zhang              X, Yang              X, Zhao              P, Cui              X, Liu              X, Yang              W, Yang              G, Xing              S. 2020.            Association of hyperuricemia with immune disorders and intestinal barrier            dysfunction. Front Physiol 11:            524236.","DOI":"10.3389\/fphys.2020.524236"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Lv              Q, Zhou              J, Wang              C, Yang              X, Han              Y, Zhou              Q, Yao              R, Sui              A. 2023.            A dynamics association study of gut barrier and microbiota in            hyperuricemia. Front Microbiol 14:            1287468.","DOI":"10.3389\/fmicb.2023.1287468"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Macia              L, Tan              J, Vieira              AT, Leach              K, Stanley              D, Luong              S, Maruya              M, Ian                McKenzie              C, Hijikata              A, Wong              C, et            al. 2015. Metabolite-sensing receptors            GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of            the inflammasome. Nat Commun 6:            6734.","DOI":"10.1038\/ncomms7734"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Wang              HB, Wang              PY, Wang              X, Wan              YL, Liu              YC. 2012.            Butyrate enhances intestinal epithelial barrier function via            up-regulation of tight junction protein Claudin-1 transcription.            Dig Dis Sci 57:            3126\u20133135.","DOI":"10.1007\/s10620-012-2259-4"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Li              Y, Li              H, Wang              R, Yu              Y, Liu              X, Tian              Z. 2023.            Protective effect of sodium butyrate on intestinal barrier damage and            uric acid reduction in hyperuricemia mice. Biomed            Pharmacother 161: 114568.","DOI":"10.1016\/j.biopha.2023.114568"},{"key":"45","doi-asserted-by":"publisher","unstructured":"45. Shi              L, Jin              L, Huang              W. 2023.            Bile acids, intestinal barrier dysfunction, and related            diseases. Cells 12:            1888.","DOI":"10.3390\/cells12141888"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Liu              C, Ruan              F, Chen              Z, Han              J, Ding              X, Han              C, Ye              L, Yang              C, Yu              Y, Zuo              Z, et            al. 2024. Phenanthrene-induced            hyperuricemia with intestinal barrier damage and the protective role of theabrownin:            modulation by gut microbiota-mediated bile acid metabolism. Sci            Total Environ 949: 174923.","DOI":"10.1016\/j.scitotenv.2024.174923"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Wang              Q, Liang              J, Zou              Q, Wang              W, Yan              G, Guo              R, Yuan              T, Wang              Y, Liu              X, Liu              Z. 2024.            Tryptophan metabolism-regulating probiotics alleviate hyperuricemia by            protecting the gut barrier integrity and enhancing colonic uric acid            excretion. J Agric Food Chem 72:            26746\u201326761.","DOI":"10.1021\/acs.jafc.4c07716"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Roager              HM, Licht              TR. 2018.            Microbial tryptophan catabolites in health and disease.            Nat Commun 9: 3294.","DOI":"10.1038\/s41467-018-05470-4"},{"key":"49","doi-asserted-by":"publisher","unstructured":"49. Parker              A, Fonseca              S, Carding              SR. 2020.            Gut microbes and metabolites as modulators of blood-brain barrier            integrity and brain health. Gut Microbes 11: 135\u2013157.","DOI":"10.1080\/19490976.2019.1638722"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Shao              T, Shao              L, Li              H, Xie              Z, He              Z, Wen              C. 2017.            Combined signature of the fecal microbiome and metabolome in patients            with gout. Front Microbiol 8:            268.","DOI":"10.3389\/fmicb.2017.00268"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Shirvani-Rad              S,                Khatibzade-Nasari              N, Ejtahed              HS, Larijani              B. 2023.            Exploring the role of gut microbiota dysbiosis in gout pathogenesis: a            systematic review. Front Med (Lausanne) 10: 1163778.","DOI":"10.3389\/fmed.2023.1163778"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Chu              Y, Sun              S, Huang              Y, Gao              Q, Xie              X, Wang              P, Li              J, Liang              L, He              X, Jiang              Y, et            al. 2021. Metagenomic analysis revealed            the potential role of gut microbiome in gout. NPJ Biofilms            Microbiomes 7: 66.","DOI":"10.1038\/s41522-021-00235-2"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. M\u00e9ndez-Salazar              EO,                V\u00e1zquez-Mellado              J,                Casimiro-Soriguer              CS, Dopazo              J, \u00c7ubuk              C,                Zamudio-Cuevas              Y,                Francisco-Balderas              A,                Mart\u00ednez-Flores              K,                Fern\u00e1ndez-Torres              J,                Lozada-P\u00e9rez              C, et            al. 2021. Taxonomic variations in the            gut microbiome of gout patients with and without tophi might have a functional impact on            urate metabolism. Mol Med 27:            50.","DOI":"10.1186\/s10020-021-00311-5"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Lin              S, Zhang              T, Zhu              L, Pang              K, Lu              S, Liao              X, Ying              S, Zhu              L, Xu              X, Wu              J, et            al. 2021. Characteristic dysbiosis in            gout and the impact of a uric acid-lowering treatment, febuxostat on the gut            microbiota. J Genet Genomics 48:            781\u2013791.","DOI":"10.1016\/j.jgg.2021.06.009"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Yang              HT, Xiu              WJ, Liu              JK, Yang              Y, Hou              XG, Zheng              YY, Wu              TT, Wu              CX, Xie              X. 2021.            Gut microbiota characterization in patients with asymptomatic            hyperuricemia: probiotics increased.            Bioengineered 12:            7263\u20137275.","DOI":"10.1080\/21655979.2021.1976897"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Sanders              ME,                Merenstein              DJ, Reid              G, Gibson              GR, Rastall              RA. 2019.            Probiotics and prebiotics in intestinal health and disease: from biology            to the clinic. Nat Rev Gastroenterol Hepatol 16: 605\u2013616.","DOI":"10.1038\/s41575-019-0173-3"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Liang              L, Meng              Z, Zhang              F, Jianguo              Z, Fang              S, Hu              Q, Tang              X, Li              Y. 2023.              <i>Lactobacillus gasseri LG08<\/i> and <i>Leuconostoc              mesenteroides LM58<\/i> exert preventive effect on the development of            hyperuricemia by repairing antioxidant system and intestinal flora            balance. Front Microbiol 14:            1211831.","DOI":"10.3389\/fmicb.2023.1211831"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Cao              J, Wang              T, Liu              Y, Zhou              W, Hao              H, Liu              Q, Yin              B, Yi              H. 2023.              <i>Lactobacillus fermentum<\/i> F40-4 ameliorates            hyperuricemia by modulating the gut microbiota and alleviating inflammation in            mice. Food Funct 14:            3259\u20133268.","DOI":"10.1039\/D2FO03701G"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Lee              Y, Kim              N, Werlinger              P, Suh              DA, Lee              H, Cho              JH, Cheng              J. 2022.            Probiotic characterization of <i>Lactobacillus brevis<\/i>            MJM60390 and <i>in vivo<\/i> assessment of its antihyperuricemic            activity. J Med Food 25:            367\u2013380.","DOI":"10.1089\/jmf.2021.K.0171"},{"key":"60","unstructured":"60. Li              Y. 2022.            Experimental study of intestinal probiotics in the treatment of mild to            moderate asymptomatic hyperuricemia. Master. Inner Monglia            Medical University 2022."},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Ni              C, Li              X, Wang              L, Li              X, Zhao              J, Zhang              H, Wang              G, Chen              W. 2021.            Lactic acid bacteria strains relieve hyperuricaemia by suppressing            xanthine oxidase activity <i>via<\/i> a short-chain fatty acid-dependent            mechanism. Food Funct 12:            7054\u20137067.","DOI":"10.1039\/D1FO00198A"},{"key":"62","doi-asserted-by":"publisher","unstructured":"62. Wu              J, Aga              L, Tang              L, Li              H, Wang              N, Yang              L, Zhang              N, Wang              X, Wang              X. 2024.              <i>Lacticaseibacillus paracasei<\/i> JS-3 isolated from            \u201cJiangshui\u201d ameliorates hyperuricemia by regulating gut microbiota and its            metabolism. Foods 13:            1371.","DOI":"10.3390\/foods13091371"},{"key":"63","first-page":"1","volume":"13","year":"2021","unstructured":"63. Wu              Y, Ye              Z, Feng              P, Li              R, Chen              X, Tian              X, Han              R, Kakade              A, Liu              P, Li              X. 2021.              <i>Limosilactobacillus fermentum<\/i> JL-3 isolated from            \u201cJiangshui\u201d ameliorates hyperuricemia by degrading uric acid.            Gut Microbes 13: 1\u201318.","journal-title":"Gut Microbes","ISSN":"https:\/\/id.crossref.org\/issn\/1949-0976","issn-type":"print"},{"key":"64","unstructured":"64. Huang              X, Wang              Z. 2022.            Effect of quadruple viable bifidobacteria combined with conventional            medication in the treatment of gout. Zhongguo Weishengtaixue            Zazhi 34:          1324\u20131329."},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Vieira              AT, Galv\u00e3o              I, Amaral              FA, Teixeira              MM, Nicoli              JR, Martins              FS. 2015.            Oral treatment with <i>Bifidobacterium longum<\/i> 51A reduced            inflammation in a murine experimental model of gout. Benef            Microbes 6: 799\u2013806.","DOI":"10.3920\/BM2015.0015"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Zeng              J, Li              Y, Zou              Y, Yang              Y, Yang              T, Zhou              Y. 2024.            Intestinal toxicity alleviation and efficacy potentiation through            therapeutic administration of <i>Lactobacillus paracasei<\/i> GY-1 in the            treatment of gout flares with colchicine. Food            Funct 15: 1671\u20131688.","DOI":"10.1039\/D3FO04858F"},{"key":"67","unstructured":"67. Wang              P, Xu              J. 2022.            Efficacy of live combined bifidobacterium, lactobacillus and enterococcus            capsules combined with febuxostat in the treatment of patients with intermittent gout            attack. Zhongguo Yiyuan Yongyao Pingjia Yu            Fenxi 22:          47\u201350."},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Kondratiuk              VE, Tarasenko              OM, Karmazina              OM, Taranchuk              VV. 2020.            Impact of the synbiotics and urate-lowering therapy on gut microbiota and            cytokine profile in patients with chronic gouty arthritis. J Med            Life 13: 490\u2013498.","DOI":"10.25122\/jml-2020-0065"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Jiang              Y, Jian              T, Song              H, Zhang              G, Ling              J. 2024.            Amelioration of hyperuricemia by cordycepin and cordyceps militaris            aqueous extract in mice via modulating gut microbiota and restoring metabolic            profile. J Pharm Biomed Anal 249:            116368.","DOI":"10.1016\/j.jpba.2024.116368"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Wang              L, Tao              Y, Wang              X, Gan              Y, Zeng              Y, Li              S, Zhu              Q. 2024.            Aqueous extract of Phellinus igniarius ameliorates hyperuricemia and            renal injury in adenine\/potassium oxonate-treated mice. Biomed            Pharmacother 177: 116859.","DOI":"10.1016\/j.biopha.2024.116859"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Cai              L, Li              Q, Deng              Y, Liu              X, Du              W, Jiang              X. 2020.            Construction and expression of recombinant uricase\u2011expressing genetically            engineered bacteria and its application in rat model of hyperuricemia.            Int J Mol Med 45:            1488\u20131500.","DOI":"10.3892\/ijmm.2020.4512"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Zhao              R, Li              Z, Sun              Y, Ge              W, Wang              M, Liu              H, Xun              L, Xia              Y. 2022.            Engineered <i>Escherichia coli<\/i> Nissle 1917 with urate            oxidase and an oxygen-recycling system for hyperuricemia treatment.            Gut Microbes 14: 2070391.","DOI":"10.1080\/19490976.2022.2070391"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. He              L, Tang              W, Huang              L, Zhou              W, Huang              S, Zou              L, Yuan              L, Men              D, Chen              S, Hu              Y. 2022.            Insulated expression of periplasmic uricase in <i>E. coli<\/i>            Nissle 1917 for the treatment of hyperuricemia.","DOI":"10.1101\/2022.04.17.488604"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Zou              ZP, Li              JL, Zhang              YF, Zhou              Y, Ye              BC. 2024.            Empowering probiotics with high xanthine transport for effective            hyperuricemia management. Gut Microbes 16: 2399213.","DOI":"10.1080\/19490976.2024.2399213"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Tong              Y, Wei              Y, Ju              Y, Li              P, Zhang              Y, Li              L, Gao              L, Liu              S, Liu              D, Hu              Y, et            al. 2023. Anaerobic purinolytic enzymes            enable dietary purine clearance by engineered gut bacteria. Cell              Chem Biol 30: 1104\u20131114.e7.","DOI":"10.1016\/j.chembiol.2023.04.008"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Gong              X, Liu              S, Xia              B, Wan              Y, Zhang              S, Zhang              B, Wang              Z, Chen              J, Xiao              F, Liang              XJ, et            al. 2025. Oral delivery of therapeutic            proteins by engineered bacterial type zero secretion system. Nat            Commun 16: 1862.","DOI":"10.1038\/s41467-025-57153-6"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Gencer              G, Mancuso              C, Chua              KJ, Ling              H, Costello              CM, Chang              MW, March              JC. 2023.            Engineering <i>Escherichia coli<\/i> for diagnosis and            management of hyperuricemia. Front Bioeng            Biotechnol 11: 1191162.","DOI":"10.3389\/fbioe.2023.1191162"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Fu              Y, Chen              YS, Xia              DY, Luo              XD, Luo              HT, Pan              J, Ma              WQ, Li              JZ, Mo              QY, Tu              Q, et            al. 2024. <i>Lactobacillus              rhamnosus<\/i> GG ameliorates hyperuricemia in a novel model.            NPJ Biofilms Microbiomes 10: 25.","DOI":"10.1038\/s41522-024-00486-9"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Wang              Z, Huang              Y, Yang              T, Song              L, Xiao              Y, Chen              Y, Chen              M, Li              M, Ren              Z. 2024.              <i>Lactococcus cremoris<\/i> D2022 alleviates hyperuricemia            and suppresses renal inflammation <i>via<\/i> potential gut-kidney            axis. Food Funct 15:            6015\u20136027.","DOI":"10.1039\/D4FO00118D"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Li              D, Zhang              M, Teng Zhu                La              A, Lyu              Z, Li              X, Feng              Y, Liu              D, Guo              Y, Hu              Y. 2023.            Quercetin-enriched <i>Lactobacillus aviarius<\/i> alleviates            hyperuricemia by hydrolase-mediated degradation of purine nucleosides.            Pharmacol Res 196: 106928.","DOI":"10.1016\/j.phrs.2023.106928"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Guarner              F, Sanders              ME, Szajewska              H, Cohen              H, Eliakim              R,                Herrera-deGuise              C, Karakan              T, Merenstein              D, Piscoya              A,                Ramakrishna              B, et            al. 2024. World gastroenterology            organisation global guidelines: probiotics and prebiotics. J            Clin Gastroenterol 58: 533\u2013553.","DOI":"10.1097\/MCG.0000000000002002"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Gibson              GR, Hutkins              R, Sanders              ME, Prescott              SL, Reimer              RA, Salminen              SJ, Scott              K, Stanton              C, Swanson              KS, Cani              PD, et            al. 2017. Expert consensus document:            The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus            statement on the definition and scope of prebiotics. Nat Rev            Gastroenterol Hepatol 14:            491\u2013502.","DOI":"10.1038\/nrgastro.2017.75"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Kalyani Nair              K, Kharb              S,                Thompkinson              DK. 2010.            Inulin dietary fiber with functional and health attributes\u2014a            review. Food Rev Int 26:            189\u2013203.","DOI":"10.1080\/87559121003590664"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Guo              Y, Yu              Y, Li              H, Ding              X, Li              X, Jing              X, Chen              J, Liu              G, Lin              Y, Jiang              C, et            al. 2021. Inulin supplementation            ameliorates hyperuricemia and modulates gut microbiota in Uox-knockout            mice. Eur J Nutr 60:            2217\u20132230.","DOI":"10.1007\/s00394-020-02414-x"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Bian              M, Wang              J, Wang              Y, Nie              A, Zhu              C, Sun              Z, Zhou              Z, Zhang              B. 2020.            Chicory ameliorates hyperuricemia via modulating gut microbiota and            alleviating LPS\/TLR4 axis in quail. Biomed            Pharmacother 131: 110719.","DOI":"10.1016\/j.biopha.2020.110719"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Ren              F, Lin              J, Zhu              M, Ma              R, Zhang              M, Chen              W, Ma              G, Chen              H, He              R, Chen              W. 2024.            Polysaccharides from Alpinia oxyphylla fruit prevent hyperuricemia by            inhibiting uric acid synthesis, modulating intestinal flora and reducing renal            inflammation. Int J Biol Macromol 278:            134782.","DOI":"10.1016\/j.ijbiomac.2024.134782"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Wang              Z, Zhang              Z, Lu              C, Zhou              J, Wang              Z, Han              J, Su              X. 2022.            Effects of Sporisorium reiliana polysaccharides and Phoenix dactylifera            monosaccharides on the gut microbiota and serum metabolism in mice with fructose-induced            hyperuricemia. Arch Microbiol 204:            436.","DOI":"10.1007\/s00203-022-03053-y"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Meng              ZQ, Tang              ZH, Yan              YX, Guo              CR, Cao              L, Ding              G, Huang              WZ, Wang              ZZ, Wang              KDG, Xiao              W, et            al. 2014. Study on the anti-gout            activity of chlorogenic acid: improvement on hyperuricemia and gouty            inflammation. Am J Chin Med 42:            1471\u20131483.","DOI":"10.1142\/S0192415X1450092X"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Zhou              X, Zhang              B, Zhao              X, Lin              Y, Wang              J, Wang              X, Hu              N, Wang              S. 2021.            Chlorogenic acid supplementation ameliorates hyperuricemia, relieves            renal inflammation, and modulates intestinal homeostasis. Food            Funct 12: 5637\u20135649.","DOI":"10.1039\/D0FO03199B"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Zhou              X, Zhang              B, Zhao              X, Lin              Y, Zhuang              Y, Guo              J, Wang              S. 2022.            Chlorogenic acid prevents hyperuricemia nephropathy via regulating            TMAO-related gut microbes and inhibiting the PI3K\/AKT\/mTOR pathway.            J Agric Food Chem 70:            10182\u201310193.","DOI":"10.1021\/acs.jafc.2c03099"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Han              QQ, Ren              QD, Guo              X, Farag              MA, Zhang              YH, Zhang              MQ, Chen              YY, Sun              ST, Sun              JY, Li              NY, et            al. 2024. Punicalagin attenuates            hyperuricemia via restoring hyperuricemia-induced renal and intestinal            dysfunctions. J Adv Res 69:            449\u2013461.","DOI":"10.1016\/j.jare.2024.03.029"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Zhang              N, Zhou              J, Zhao              L, Zhao              Z, Wang              S, Zhang              L, Zhou              F. 2023.            Ferulic acid supplementation alleviates hyperuricemia in            high-fructose\/fat diet-fed rats <i>via<\/i> promoting uric acid excretion and            mediating the gut microbiota. Food Funct 14: 1710\u20131725.","DOI":"10.1039\/D2FO03332A"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Lian              Y, Fu              G, Liang              X, He              X, Xu              J, Fan              H, Wan              Y. 2024.            Combination of Artemisia selengensis Turcz leaves polysaccharides and            dicaffeoylquinic acids could be a potential inhibitor for hyperuricemia.            Int J Biol Macromol 271: 132687.","DOI":"10.1016\/j.ijbiomac.2024.132687"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. Huang              KC, Chang              YT, Pranata              R, Cheng              YH, Chen              YC, Kuo              PC, Huang              YH, Tzen              JTC, Chen              RJ. 2023.            Alleviation of hyperuricemia by strictinin in AML12 mouse hepatocytes            treated with xanthine and in mice treated with potassium oxonate.            Biology (Basel) 12: 329.","DOI":"10.3390\/biology12020329"},{"key":"95","doi-asserted-by":"publisher","unstructured":"95. Dias              MC, Pinto              DCGA, Silva              AMS. 2021.            Plant flavonoids: chemical characteristics and biological            activity. Molecules 26:            5377.","DOI":"10.3390\/molecules26175377"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96. Cheng              LC,                Murugaiyah              V, Chan              KL. 2015.            Flavonoids and phenylethanoid glycosides from Lippia nodiflora as            promising antihyperuricemic agents and elucidation of their mechanism of            action. J Ethnopharmacol 176:            485\u2013493.","DOI":"10.1016\/j.jep.2015.11.025"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97. Mo              SF, Zhou              F, Lv              YZ, Hu              QH, Zhang              DM, Kong              LD. 2007.            Hypouricemic action of selected flavonoids in mice: structure-activity            relationships. Biol Pharm Bull 30:            1551\u20131556.","DOI":"10.1248\/bpb.30.1551"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98. Yuan              L, Bao              Z, Ma              T, Lin              S. 2021.            Hypouricemia effects of corn silk flavonoids in a mouse model of            potassium oxonated-induced hyperuricemia. J Food            Biochem e13856: e13856.","DOI":"10.1111\/jfbc.13856"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99. Tumova              S, Shi              Y, Carr              IM,                Williamson              G. 2021.            Effects of quercetin and metabolites on uric acid biosynthesis and            consequences for gene expression in the endothelium. Free Radic            Biol Med 162: 191\u2013201.","DOI":"10.1016\/j.freeradbiomed.2020.10.017"},{"key":"100","doi-asserted-by":"publisher","unstructured":"100. Toyoda              Y, Takada              T, Saito              H, Hirata              H,                Ota-Kontani              A, Tsuchiya              Y, Suzuki              H. 2022.            Identification of inhibitory activities of dietary flavonoids against            URAT1, a renal urate re-absorber: <i>in vitro<\/i> screening and fractional            approach focused on rooibos leaves. Nutrients 14: 575.","DOI":"10.3390\/nu14030575"},{"key":"101","unstructured":"101. Chen              N. 2023. The          anti-hyperuricemia activity, mechanism and material basis of saffron floral bio-residues.          Doctor. China Academy of Chinese Medical Sciences, 2023."},{"key":"102","doi-asserted-by":"crossref","unstructured":"102. Chen              N, Wang              R, Li              H, Wang              W, Wang              L, Yin              X, Yao              R, Yang              B. 2022.            Flavonoid extract of saffron by-product alleviates hyperuricemia via            inhibiting xanthine oxidase and modulating gut microbiota.            Phytother Res 36:            4604\u20134619.","DOI":"10.1002\/ptr.7579"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103. Lu              C, Tang              S, Han              J, Fan              S, Huang              Y, Zhang              Z, Zhou              J, Ming              T, Li              Y, Su              X. 2021.              <i>Apostichopus japonicus<\/i> oligopeptide induced            heterogeneity in the gastrointestinal tract microbiota and alleviated hyperuricemia in a            microbiota-dependent manner. Mol Nutr Food Res 65: e2100147.","DOI":"10.1002\/mnfr.202100147"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104. Wu              C, Hu              Q, Peng              X, Luo              J, Zhang              G. 2023.            Marine fish protein peptide regulating potassium oxonate-induced            intestinal dysfunction in hyperuricemia rats helps alleviate kidney            inflammation. J Agric Food Chem 71:            320\u2013330.","DOI":"10.1021\/acs.jafc.2c04017"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105. Chang              WC, Chu              MT, Hsu              CY, Wu              YJJ, Lee              JY, Chen              TJ, Chung              WH, Chen              DY, Hung              SI. 2019.            Rhein, an anthraquinone drug, suppresses the nlrp3 inflammasome and            macrophage activation in urate crystal-induced gouty inflammation.            Am J Chin Med 47:            135\u2013151.","DOI":"10.1142\/S0192415X19500071"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106. Xing              Z, Zhang              F, Gao              M, Xu              Z, Liu              Y, Shen              G. 2024.            Effect and mechanism of rhein-praseodymium complex on intestinal uric            acid excretion in rats with renal injury and hyperuricemia. Curr            Med Chem 32: 2838\u20132853.","DOI":"10.2174\/0109298673268642231214061615"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107. Lin              G, Yu              Q, Xu              L, Huang              Z, Mai              L, Jiang              L, Su              Z, Xie              J, Li              Y, Liu              Y, et            al. 2021. Berberrubine attenuates            potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate            transporters and JAK2\/STAT3 signaling pathway. Eur J            Pharmacol 912: 174592.","DOI":"10.1016\/j.ejphar.2021.174592"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108. Li              Q, Huang              Z, Liu              D, Zheng              J, Xie              J, Chen              J, Zeng              H, Su              Z, Li              Y. 2021.            Effect of berberine on hyperuricemia and kidney injury: a network            pharmacology analysis and experimental validation in a mouse model.            Drug Des Devel Ther 15:            3241\u20133254.","DOI":"10.2147\/DDDT.S317776"},{"key":"109","doi-asserted-by":"crossref","unstructured":"109. Zhong              L, Lin              Y, Gong              S, Wu              X, Liu              Y, Chen              J, Li              Y, Yan              F, Su              Z, Xie              Q. 2023.            Oxyberberrubine, a novel liver microsomes-mediated secondary metabolite            of berberine, alleviates hyperuricemic nephropathy in mice.            Phytomedicine 108: 154521.","DOI":"10.1016\/j.phymed.2022.154521"},{"key":"110","doi-asserted-by":"crossref","unstructured":"110. Cheng              H, Liu              J, Tan              Y, Feng              W, Peng              C. 2022.            Interactions between gut microbiota and berberine, a necessary procedure            to understand the mechanisms of berberine. J Pharm            Anal 12: 541\u2013555.","DOI":"10.1016\/j.jpha.2021.10.003"},{"key":"111","doi-asserted-by":"crossref","unstructured":"111. Shan              B, Wu              M, Chen              T, Tang              W, Li              P, Chen              J. 2022.            Berberine attenuates hyperuricemia by regulating urate transporters and            gut microbiota. Am J Chin Med 50:            2199\u20132221.","DOI":"10.1142\/S0192415X22500951"},{"key":"112","doi-asserted-by":"crossref","unstructured":"112. Zhang              ZW, Cong              L, Peng              R, Han              P, Ma              SR, Pan              LB, Fu              J, Yu              H, Wang              Y, Jiang              JD. 2021.            Transformation of berberine to its demethylated metabolites by the CYP51            enzyme in the gut microbiota. J Pharm Anal 11: 628\u2013637.","DOI":"10.1016\/j.jpha.2020.10.001"},{"key":"113","doi-asserted-by":"crossref","unstructured":"113. Yu              H, Lou              Z, Wu              T, Wan              X, Huang              H, Wu              Y, Li              B, Tu              Y, He              P, Liu              J. 2024.            Mechanisms of epigallocatechin gallate (EGCG) in ameliorating            hyperuricemia: insights into gut microbiota and intestinal function in a mouse            model. Food Funct 15:            6068\u20136081.","DOI":"10.1039\/D4FO01606H"},{"key":"114","doi-asserted-by":"crossref","unstructured":"114. Wang              LM, Wang              P, Teka              T, Zhang              YC, Yang              WZ, Zhang              Y, Wang              T, Liu              LX, Han              LF, Liu              CX. 2020.              <sup>1<\/sup>H NMR and UHPLC\/Q-Orbitrap-MS-based metabolomics combined            with 16S rRNA gut microbiota analysis revealed the potential regulation mechanism of            nuciferine in hyperuricemia rats. J Agric Food            Chem 68: 14059\u201314070.","DOI":"10.1021\/acs.jafc.0c04985"},{"key":"115","doi-asserted-by":"crossref","unstructured":"115. Li              X, Chen              Y, Gao              X, Wu              Y, El-Seedi              HR, Cao              Y, Zhao              C. 2021.            Antihyperuricemic effect of green alga <i>Ulva lactuca<\/i>            ulvan through regulating urate transporters. J Agric Food            Chem 69: 11225\u201311235.","DOI":"10.1021\/acs.jafc.1c03607"},{"key":"116","doi-asserted-by":"crossref","unstructured":"116. Li              X, Gao              X, Zhang              H, Liu              Y, Sarker              MMR, Wu              Y, Chen              X, Zhao              C. 2021.            The anti-hyperuricemic effects of green alga <i>Enteromorpha              prolifera<\/i> polysaccharide via regulation of the uric acid transporters              <i>in vivo<\/i>. Food Chem Toxicol 158: 112630.","DOI":"10.1016\/j.fct.2021.112630"},{"key":"117","doi-asserted-by":"crossref","unstructured":"117. Qi              X, Ma              Y, Guan              K, Zhao              L, Ma              Y, Wang              R. 2024.            Whey protein peptide Pro-Glu-Trp ameliorates hyperuricemia by enhancing            intestinal uric acid excretion, modulating the gut microbiota, and protecting the            intestinal barrier in rats. J Agric Food Chem 72: 2573\u20132584.","DOI":"10.1021\/acs.jafc.3c00984"},{"key":"118","doi-asserted-by":"crossref","unstructured":"118. Wang              P, Zhang              X, Zheng              X, Gao              J, Shang              M, Xu              J, Liang              H. 2022.            Folic acid protects against hyperuricemia in C57BL\/6J mice via            ameliorating gut-kidney axis dysfunction. J Agric Food            Chem 70: 15787\u201315803.","DOI":"10.1021\/acs.jafc.2c06297"},{"key":"119","doi-asserted-by":"crossref","unstructured":"119. Sun              X, Wen              J, Guan              B, Li              J, Luo              J, Li              J, Wei              M, Qiu              H. 2022.            Folic acid and zinc improve hyperuricemia by altering the gut microbiota            of rats with high-purine diet-induced hyperuricemia. Front            Microbiol 13: 907952.","DOI":"10.3389\/fmicb.2022.907952"},{"key":"120","unstructured":"120. Liu              S, Lu              Y, Xuan              X, Zhang              N, Xiu              H, Wang              T, Yu              D. 2024.            Discussion on the effect and mechanism of total saponins of              <i>Dioscoreae Nipponicae Rhizoma<\/i> on hyperuricemia rats based on 16S rRNA            sequencing. Zhonghua Zhongyiyao Zazhi 39: 163\u2013167."},{"key":"121","unstructured":"121. Yu              D, Wang              X, Wang              Y, Yuan              J, Liu              S. 2023.            Effects of total saponins of rhizoma dioscorea nipponica on intestinal            flora and short-chain fatty acid metabolism in rats with hyperuricemia.            Acta Chinese Medicine and Pharmacology 51:            27\u201333."},{"key":"122","doi-asserted-by":"crossref","unstructured":"122. Ji              X, Yu              L, Han              C, Gao              H, Cai              Y, Li              J, He              Y, Lu              H, Song              G, Xue              P. 2024.            Investigating the effects of rare ginsenosides on hyperuricemia and            associated sperm damage via nontargeted metabolomics and gut microbiota.            J Ethnopharmacol 332: 118362.","DOI":"10.1016\/j.jep.2024.118362"},{"key":"123","doi-asserted-by":"crossref","unstructured":"123. Wang              R, Halimulati              M, Huang              X, Ma              Y, Li              L, Zhang              Z. 2023.            Sulforaphane-driven reprogramming of gut microbiome and metabolome            ameliorates the progression of hyperuricemia. J Adv            Res 52: 19\u201328.","DOI":"10.1016\/j.jare.2022.11.003"},{"key":"124","doi-asserted-by":"crossref","unstructured":"124. Chen              F, Wen              Q, Jiang              J, Li              HL, Tan              YF, Li              YH, Zeng              NK. 2016.            Could the gut microbiota reconcile the oral bioavailability conundrum of            traditional herbs? J Ethnopharmacol 179: 253\u2013264.","DOI":"10.1016\/j.jep.2015.12.031"},{"key":"125","doi-asserted-by":"crossref","unstructured":"125. Liu              ZQ, Sun              X, Liu              ZB, Zhang              T, Zhang              LL, Wu              CJ. 2022.            Phytochemicals in traditional Chinese medicine can treat gout by            regulating intestinal flora through inactivating NLRP3 and inhibiting XOD            activity. J Pharm Pharmacol 74:            919\u2013929.","DOI":"10.1093\/jpp\/rgac024"},{"key":"126","unstructured":"126. Li              D, Yang              L, Wang              D, Chen              J. 2023.            Research progress on the related mechanism of decreased intestinal uric            acid excretion in hyperuricemia and the intervention of traditional chinese            medicine. Chinese J Integrated Traditional and Western            Medicine 43:          369\u2013373."},{"key":"127","unstructured":"127. Shen              J, Wang              H, Liu              Y. 2023.            Research progress of traditional Chinese medicine in the treatment of            gouty arthritis. J Clinical Med Practice 27: 123\u2013130."},{"key":"128","doi-asserted-by":"crossref","unstructured":"128. Chen              X, Ge              HZ, Lei              SS, Jiang              ZT, Su              J, He              X, Zheng              X, Wang              HY, Yu              QX, Li              B, et            al. 2020. Dendrobium officinalis six            nostrum ameliorates urate under-excretion and protects renal dysfunction in lipid            emulsion-induced hyperuricemic rats. Biomed            Pharmacother 132: 110765.","DOI":"10.1016\/j.biopha.2020.110765"},{"key":"129","doi-asserted-by":"crossref","unstructured":"129. Lin              X, Shao              T, Huang              L, Wen              X, Wang              M, Wen              C, He              Z. 2020.            Simiao decoction alleviates gouty arthritis by modulating proinflammatory            cytokines and the gut ecosystem. Front            Pharmacol 11: 955.","DOI":"10.3389\/fphar.2020.00955"},{"key":"130","unstructured":"130. Xie              Z, Wen              C, Bao              H, Sun              J. 2011.            Effect of Quzhuo Tongbi recipe on levels of xanthine oxidase in            hyperuricemia rats. China J Traditional Chinese            Med 26:          1398\u20131400."},{"key":"131","unstructured":"131. Liu              Q, Yu              Y, Li              H, Wen              C, He              Z. 2019.            Regulation of Quzhuo Tongbi preseription on gut microbiota of model rats            with abnormal uric acid metabolism. Zhonghua Zhongyiyao            Zazhi 34:          1722\u20131726."},{"key":"132","doi-asserted-by":"crossref","unstructured":"132. Wen              X, Lou              Y, Song              S, He              Z, Chen              J, Xie              Z, Shi              X, Wen              C, Shao              T. 2021.            Qu-Zhuo-Tong-Bi decoction alleviates gouty arthritis by regulating            butyrate-producing bacteria in mice. Front            Pharmacol 11: 610556.","DOI":"10.3389\/fphar.2020.610556"},{"key":"133","doi-asserted-by":"crossref","unstructured":"133. Wang              X, Long              H, Chen              M, Zhou              Z, Wu              Q, Xu              S, Li              G, Lu              Z. 2022.            Modified Baihu decoction therapeutically remodels gut microbiota to            inhibit acute gouty arthritis. Front Physiol 13: 1023453.","DOI":"10.3389\/fphys.2022.1023453"},{"key":"134","unstructured":"134. Guo              Y, Gu              H. 2023.            Effect of Liji decoction combined with acupoint application on acute            gouty arthritis. Zhongguo Laonianxue Zazhi 43: 2653\u20132657."},{"key":"135","doi-asserted-by":"crossref","unstructured":"135. Antushevich              H. 2020.            Fecal microbiota transplantation in disease therapy.            Clin Chim Acta 503:            90\u201398.","DOI":"10.1016\/j.cca.2019.12.010"},{"key":"136","doi-asserted-by":"crossref","unstructured":"136. Nanjing            consensus on methodology of washed microbiota transplantation 2020.            Chin Med J 133:            2330\u20132332.","DOI":"10.1097\/CM9.0000000000000954"},{"key":"137","doi-asserted-by":"crossref","unstructured":"137. Xie              WR, Yang              XY, Deng              ZH, Zheng              YM, Zhang              R, Wu              LH, Cai              JY, Kong              LP, Xia              HHX, He              XX. 2022.            Effects of washed microbiota transplantation on serum uric acid levels,            symptoms, and intestinal barrier function in patients with acute and recurrent gout: a            pilot study. Dig Dis 40:            684\u2013690.","DOI":"10.1159\/000521273"},{"key":"138","doi-asserted-by":"crossref","unstructured":"138. Cai              JR, Chen              XW, He              YJ, Wu              B, Zhang              M, Wu              LH. 2022.            Washed microbiota transplantation reduces serum uric acid levels in            patients with hyperuricaemia. World J Clin            Cases 10: 3401\u20133413.","DOI":"10.12998\/wjcc.v10.i11.3401"},{"key":"139","doi-asserted-by":"crossref","unstructured":"139. Han              J, Wang              Z, Lu              C, Zhou              J, Li              Y, Ming              T, Zhang              Z, Wang              ZJ, Su              X. 2021.            The gut microbiota mediates the protective effects of anserine            supplementation on hyperuricaemia and associated renal inflammation.            Food Funct 12:          9030\u20139042.","DOI":"10.1039\/D1FO01884A"},{"key":"140","doi-asserted-by":"crossref","unstructured":"140. Han              J, Wang              X, Tang              S, Lu              C, Wan              H, Zhou              J, Li              Y, Ming              T, Wang              ZJ, Su              X. 2020.            Protective effects of tuna meat oligopeptides (TMOP) supplementation on            hyperuricemia and associated renal inflammation mediated by gut            microbiota. FASEB J 34:            5061\u20135076.","DOI":"10.1096\/fj.201902597RR"},{"key":"141","unstructured":"141. Zhang              Y, Mao              X, Xiao              Y, Cai              T, Guo              J, Chen              P, Zhang              P, Liu              J, Chen              Y, Qiu              M, et            al. 2023. Effects of Tongfengning on            intestinal flora and intestinal uric acid metabolism in model mice of hyperuricemia of            spleen deficiency with exuberance of dampness syndrome. J Tradit            Chin Med 64:          2232\u20132240."},{"key":"142","doi-asserted-by":"crossref","unstructured":"142. Wu              D, Chen              R, Li              Q, Lai              X, Sun              L, Zhang              Z, Wen              S, Sun              S, Cao              F. 2022.            Tea (<i>Camellia sinensis<\/i>) ameliorates hyperuricemia via            uric acid metabolic pathways and gut microbiota.            Nutrients 14: 2666.","DOI":"10.3390\/nu14132666"},{"key":"143","doi-asserted-by":"crossref","unstructured":"143. Chen              Y, Pei              C, Chen              Y, Xiao              X, Zhang              X, Cai              K, Deng              S, Liang              R, Xie              Z, Li              P, et            al. 2023. Kidney tea ameliorates            hyperuricemia in mice via altering gut microbiota and restoring metabolic            profile. Chem Biol Interact 376:            110449.","DOI":"10.1016\/j.cbi.2023.110449"},{"key":"144","doi-asserted-by":"crossref","unstructured":"144. Feng              Y, Yu              Y, Chen              Z, Wang              L, Ma              J, Bai              X, Sun              Y, Wang              D. 2022.            Effects of \u03b2-carotin and green tea powder diets on alleviating the            symptoms of gouty arthritis and improving gut microbiota in C57BL\/6          mice. Front Microbiol 13:            837182.","DOI":"10.3389\/fmicb.2022.837182"},{"key":"145","unstructured":"145. Deng              X. 2020.            Research progress on pharmacotherapy for gout and            hyperuricemia. J China Prescription Drug 18: 24\u201326 (in          Chinese)."},{"key":"146","doi-asserted-by":"crossref","unstructured":"146. Kim              SC, Newcomb              C, Margolis              D, Roy              J, Hennessy              S. 2013.            Severe cutaneous reactions requiring hospitalization in allopurinol            initiators: a population-based cohort study. Arthritis Care Res            (Hoboken) 65: 578\u2013584.","DOI":"10.1002\/acr.21817"},{"key":"147","doi-asserted-by":"crossref","unstructured":"147. Keller              SF, Lu              N, Blumenthal              KG, Rai              SK, Yokose              C, Choi              JWJ, Kim              SC, Zhang              Y, Choi              HK. 2018.            Racial\/ethnic variation and risk factors for allopurinol-associated            severe cutaneous adverse reactions: a cohort study. Ann Rheum            Dis 77: 1187\u20131193.","DOI":"10.1136\/annrheumdis-2017-212905"},{"key":"148","doi-asserted-by":"crossref","unstructured":"148. White              WB, Saag              KG, Becker              MA, Borer              JS, Gorelick              PB, Whelton              A, Hunt              B, Castillo              M,                Gunawardhana              L, CARES            Investigators. 2018. Cardiovascular safety of            febuxostat or allopurinol in patients with gout. N Engl J            Med 378: 1200\u20131210.","DOI":"10.1056\/NEJMoa1710895"},{"key":"149","doi-asserted-by":"crossref","unstructured":"149. Kang              EH, Shin              A, Park              CS, Lee              EB, Lee              YJ, Curhan              G, Choi              HK. 2024.            Risk of urolithiasis associated with allopurinol versus benzbromarone            among patients with gout: a population-based cohort study.            Rheumatology (Oxford) 63:            2433\u20132441.","DOI":"10.1093\/rheumatology\/keae262"},{"key":"150","doi-asserted-by":"crossref","unstructured":"150. Wang              Z, Li              Y, Liao              W, Huang              J, Liu              Y, Li              Z, Tang              J. 2022.            Gut microbiota remodeling: a promising therapeutic strategy to confront            hyperuricemia and gout. Front Cell Infect            Microbiol 12: 935723.","DOI":"10.3389\/fcimb.2022.935723"},{"key":"151","doi-asserted-by":"crossref","unstructured":"151. Mimee              M, Citorik              RJ, Lu              TK. 2016.            Microbiome therapeutics\u2014advances and challenges.            Adv Drug Deliv Rev 105 Pt A:            44\u201354.","DOI":"10.1016\/j.addr.2016.04.032"},{"key":"152","doi-asserted-by":"crossref","unstructured":"152. Whitaker              WR, Russ              ZN, Stanley                Shepherd              E, Popov              LM, Louie              A, Lam              K, Zong              DM, Gill              CCC, Gehrig              JL, Rishi              HS, et            al. 2025. Controlled colonization of            the human gut with a genetically engineered microbial therapeutic.            Science 389: 303\u2013308.","DOI":"10.1126\/science.adu8000"},{"key":"153","doi-asserted-by":"crossref","unstructured":"153. Yu              KB, Chandra              F,                Coley-O\u2019Rourke              EJ, Paulson              ET, Novoselov              A, Zhang              D, Finnigan              D, Paramo              J,                Lopez-Romero              A, Dong              TS, et            al. 2025. An engineered gut bacterium            protects against dietary methylmercury exposure in pregnant mice.            Cell Host Microbe 33:            621\u2013631.e7.","DOI":"10.1016\/j.chom.2025.04.009"},{"key":"154","doi-asserted-by":"crossref","unstructured":"154. Zou              ZP, Wang              XG, Shi              XR, Sun              ST, Mi              J, Zhang              XP, Yin              BC, Zhou              Y, Ye              BC. 2025.            Self-adjusting engineered probiotic for targeted tumor colonization and            local therapeutics delivery. Adv Sci (Weinh) 12: e06486.","DOI":"10.1002\/advs.202406486"},{"key":"155","doi-asserted-by":"crossref","unstructured":"155. Suez              J, Zmora              N, Segal              E, Elinav              E. 2019.            The pros, cons, and many unknowns of probiotics.            Nat Med 25: 716\u2013729.","DOI":"10.1038\/s41591-019-0439-x"},{"key":"156","doi-asserted-by":"crossref","unstructured":"156. Veiga              P, Suez              J, Derrien              M, Elinav              E. 2020.            Moving from probiotics to precision probiotics.            Nat Microbiol 5:          878\u2013880.","DOI":"10.1038\/s41564-020-0721-1"},{"key":"157","unstructured":"157. Si              K, Wang              Y. 2023.            Current situation and prospect of diagnosis and treatment of gout and            hyperuricemia with integrated traditional Chinese and western medicine.            Zhongguo Linchuang Baojian Zazhi 26:            606\u2013609 (in Chinese)."},{"key":"158","unstructured":"158. Li              H. 2024.          Meta-analysis of the efficacy of Simiao Powder in the treatment of gouty arthritis. M.S.          thesis. Hu bei University of Chinese Medicine, 2024  (in          Chinese)."},{"key":"159","unstructured":"159. Wang              Z, Li              J. 2025.            Research progress of traditional Chinese medicine in the treatment of            hyperuricemia and gout complicated with metabolic diseases.            Zhongguo Zhongyiyao Xiandai Yuancheng Jiaoyu 23:            151\u2013153 (in Chinese)."},{"key":"160","doi-asserted-by":"crossref","unstructured":"160. Wang              Y, Sun              J, Xie              S, Zhou              Y, Wang              T, Liu              Z, Li              C, Gao              L, Pan              T. 2023.            Increased abundance of bacteria of the family Muribaculaceae achieved by            fecal microbiome transplantation correlates with the inhibition of kidney calcium            oxalate stone deposition in experimental rats. Front Cell Infect            Microbiol 13: 1145196.","DOI":"10.3389\/fcimb.2023.1145196"},{"key":"161","doi-asserted-by":"crossref","unstructured":"161. DeFilipp              Z, Bloom              PP, Torres                Soto              M, Mansour              MK, Sater              MRA, Huntley              MH, Turbett              S, Chung              RT, Chen              YB, Hohmann              EL. 2019.            Drug-resistant <i>E. coli<\/i> bacteremia transmitted by fecal            microbiota transplant. N Engl J Med 381: 2043\u20132050.","DOI":"10.1056\/NEJMoa1910437"},{"key":"162","doi-asserted-by":"crossref","unstructured":"162. Huang              L, Chen              C, Meng              J, Yan              Q, Luo              G, Sha              S, Xing              Y, Liu              C, Xu              M, Zhao              L, et            al. 2025. Metagenome-based            characterization of the gut virome signatures in patients with gout.            J Med Virol 97: e70336.","DOI":"10.1002\/jmv.70336"}],"container-title":["Bioscience of Microbiota, Food and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/45\/2\/45_2025-042\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T04:01:21Z","timestamp":1776484881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bmfh\/45\/2\/45_2025-042\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":162,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.12938\/bmfh.2025-042","relation":{},"ISSN":["2186-3342"],"issn-type":[{"value":"2186-3342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"2025-042"}}